Post Acute COVID Syndrome (PACS) WEBINAR - Web Post Acute COVID Syndrome (PACS) WEBINAR - Mobile

Join leading clinicians from Mount Sinai, along with our medical experts as they explain Post Acute COVID Syndrome (PACS) and the wide range of physical and mental health issues people are experiencing after their initial COVID diagnosis. This compelling 30-minute interview with the frontline clinical team from Mount Sinai answers questions about Long COVID, Post Acute COVID Syndrome (PACS) and Post Acute Sequelae of COVID-19 (PASC)

WHO THIS IS FOR

This webinar is for clinicians, as COVID continues to remain a threat to global public health and the awareness of this syndrome increases. This webinar is also for people experiencing the long term side effects of COVID (fatigue, brain fog, loss of taste & smell, joint pain and depression) and those caring for someone recently diagnosed

LEARNING OBJECTIVES

Upon completion of this webinar, viewers will be able to:

  • Define PACS, Long Haul COVID, and PASC
  • Describe the symptoms and body systems impacted by PACS
  • Understand treatment and therapy approaches being explored
  • Provide considerations for use of Respiratory Muscle Training (RMT) in this population
  • Hear from an expert panel working with those impacted by PACS
  • Review current research related to this topic

HELPFUL LINKS

WATCH THE VIDEO

 

MEET THE EXPERTS

Elizabeth (Betsy) Page
MA, CCC/SLP, Master Clinician
HOST

Elizabeth (Betsy) Page has been a Speech-Language Pathologist since 2005. She is a graduate of the University of Central Florida and has experience in various adult rehabilitation settings. Betsy promotes an interdisciplinary approach to medical-based rehabilitation assessment and treatment.

She is a leader in her field and has enjoyed great outcomes working with those impacted by Respiratory Muscle Weakness among various other medical conditions and functional limitations. Betsy has a passion for clinical program development, implementation, and education. She also serves as Master Clinician for PN Medical.

Dr. Nina Bausek
PN Medical Chief Scientist
EXPERT

Nina Bausek is a graduate of the University of Vienna. She developed her scientific and leadership skills doing research and teaching at the University of Oxford and the University of Sheffield in the UK. She excels as a biologist and geneticist and has been granted funding from Cancer Research in the UK. Her findings have been published in International Journals. She worked in the areas of fertility, immunology and oncology as a researcher. She serves as Chief Scientist for PN Medical.

Dr Jenna Tosto-Mancuso, DPT
Mount Sinai
EXPERT

Dr Tosto-Mancuso is a physical therapist and Board Certified Clinical Specialist in Neurologic Physical Therapy. Her clinical and research interests include the development of novel rehabilitation approaches and technology in the care of individuals following neurological injury. She serves as the clinical lead of the Mount Sinai Hospital Post Acute COVID19 Syndrome (PACS) Physical Therapy program.

Dr Laura Tabacof, MD
Mount Sinai
EXPERT

Dr Tabacof specializes in rehabilitation medicine. As a Post-Doctoral Fellow, she investigates the pragmatic implementation and efficacy of healthtech initiatives for chronic pain. At the Mount Sinai Post-acute COVID-19 Syndrome (PACS) Clinic, Dr Tabacof has been spearheading the analysis of clinical data to characterize and quantify impairment in long COVID. She currently serves as an active member of the AAPMR and the WHO task forces addressing the rehabilitation of long COVID.

Dr Jamie Wood, PT PhD
Mount Sinai
EXPERT

Dr Wood is an Australian-trained respiratory physiotherapist and has worked with adults with cystic fibrosis and other chronic respiratory diseases for over 14 years. Dr Wood joined the Abilities Research Center at Mount Sinai in 2020, and his current research focuses on the development and testing of novel solutions for people with chronic disease and disabilities. Dr Wood has also been assisting in the coordination of clinical research programs for people with post-acute COVID-19 syndrome.